Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Anikó Borbás:

Search results

Items: 1 to 20 of 55

1.

Photoinitiated Thiol-Ene Reactions of Various 2,3-Unsaturated O-, C- S- and N-Glycosides - Scope and Limitations Study.

Kelemen V, Csávás M, Hotzi J, Herczeg M, Singh P, Rathi B, Herczegh P, Jain N, Borbás A.

Chem Asian J. 2020 Jan 31. doi: 10.1002/asia.201901560. [Epub ahead of print]

PMID:
32003941
2.

Stereoselective Synthesis of Carbon-Sulfur-Bridged Glycomimetics by Photoinitiated Thiol-Ene Coupling Reactions.

Csávás M, Eszenyi D, Mező E, Lázár L, Debreczeni N, Tóth M, Somsák L, Borbás A.

Int J Mol Sci. 2020 Jan 16;21(2). pii: E573. doi: 10.3390/ijms21020573.

3.
4.

Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.

Nemes D, Kovács R, Nagy F, Tóth Z, Herczegh P, Borbás A, Kelemen V, Pfliegler WP, Rebenku I, Hajdu PB, Fehér P, Ujhelyi Z, Fenyvesi F, Váradi J, Vecsernyés M, Bácskay I.

Eur J Pharm Sci. 2020 Feb 15;143:105162. doi: 10.1016/j.ejps.2019.105162. Epub 2019 Nov 20.

5.

Synthesis of β-d-galactopyranoside-Presenting Glycoclusters, Investigation of Their Interactions with Pseudomonas aeruginosa Lectin A (PA-IL) and Evaluation of Their Anti-Adhesion Potential.

Malinovská L, Thai Le S, Herczeg M, Vašková M, Houser J, Fujdiarová E, Komárek J, Hodek P, Borbás A, Wimmerová M, Csávás M.

Biomolecules. 2019 Nov 1;9(11). pii: E686. doi: 10.3390/biom9110686.

6.

Comparison of Carbohydrate Force Fields Using Gaussian Accelerated Molecular Dynamics Simulations and Development of Force Field Parameters for Heparin-Analogue Pentasaccharides.

Balogh G, Gyöngyösi T, Timári I, Herczeg M, Borbás A, Fehér K, Kövér KE.

J Chem Inf Model. 2019 Nov 25;59(11):4855-4867. doi: 10.1021/acs.jcim.9b00666. Epub 2019 Oct 22.

PMID:
31593467
7.

Stereoselective Thioconjugation by Photoinduced Thiol-ene Coupling Reactions of Hexo- and Pentopyranosyl d- and l-Glycals at Low-Temperature-Reactivity and Stereoselectivity Study.

Kelemen V, Bege M, Eszenyi D, Debreczeni N, Bényei A, Stürzer T, Herczegh P, Borbás A.

Chemistry. 2019 Nov 18;25(64):14555-14571. doi: 10.1002/chem.201903095. Epub 2019 Oct 1.

8.

Dataset on structure, stability and myocardial effects of a new hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety.

Szőke K, Czompa A, Lekli I, Szabados-Fürjesi P, Herczeg M, Csávás M, Borbás A, Herczegh P, Tósaki Á.

Data Brief. 2019 Jun 12;25:104146. doi: 10.1016/j.dib.2019.104146. eCollection 2019 Aug.

9.

Investigation of the Binding Affinity of a Broad Array of l-Fucosides with Six Fucose-Specific Lectins of Bacterial and Fungal Origin.

Thai Le S, Malinovska L, Vašková M, Mező E, Kelemen V, Borbás A, Hodek P, Wimmerová M, Csávás M.

Molecules. 2019 Jun 18;24(12). pii: E2262. doi: 10.3390/molecules24122262.

10.

Rhamnose Binding Protein as an Anti-Bacterial Agent-Targeting Biofilm of Pseudomonas aeruginosa.

Fu TK, Ng SK, Chen YE, Lee YC, Demeter F, Herczeg M, Borbás A, Chiu CH, Lan CY, Chen CL, Chang MD.

Mar Drugs. 2019 Jun 14;17(6). pii: E355. doi: 10.3390/md17060355.

11.

Synthesis and Cytostatic Effect of 3'-deoxy-3'-C-Sulfanylmethyl Nucleoside Derivatives with d-xylo Configuration.

Bege M, Kiss A, Kicsák M, Bereczki I, Baksa V, Király G, Szemán-Nagy G, Szigeti MZ, Herczegh P, Borbás A.

Molecules. 2019 Jun 10;24(11). pii: E2173. doi: 10.3390/molecules24112173.

12.

New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.

Szűcs Z, Ostorházi E, Kicsák M, Nagy L, Borbás A, Herczegh P.

J Antibiot (Tokyo). 2019 Jul;72(7):524-534. doi: 10.1038/s41429-019-0164-1. Epub 2019 Mar 15.

PMID:
30874609
13.

A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety.

Szőke K, Czompa A, Lekli I, Szabados-Fürjesi P, Herczeg M, Csávás M, Borbás A, Herczegh P, Tósaki Á.

Eur J Pharm Sci. 2019 Apr 1;131:159-166. doi: 10.1016/j.ejps.2019.02.020. Epub 2019 Feb 16.

14.

Fluorescence assay to predict activity of the glycopeptide antibiotics.

Vimberg V, Gazak R, Szűcs Z, Borbás A, Herczegh P, Cavanagh JP, Zieglerova L, Závora J, Adámková V, Balikova Novotna G.

J Antibiot (Tokyo). 2019 Feb;72(2):114-117. doi: 10.1038/s41429-018-0120-5. Epub 2018 Nov 30.

PMID:
30504918
15.

Synthesis of thiomaltooligosaccharides by a thio-click approach.

Lázár L, Borbás A, Somsák L.

Carbohydr Res. 2018 Dec;470:8-12. doi: 10.1016/j.carres.2018.09.005. Epub 2018 Sep 27.

PMID:
30286336
16.

Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis.

Demeter F, Gyöngyösi T, Bereczky Z, Kövér KE, Herczeg M, Borbás A.

Sci Rep. 2018 Sep 13;8(1):13736. doi: 10.1038/s41598-018-31854-z.

17.

Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.

Szűcs Z, Kelemen V, Le Thai S, Csávás M, Rőth E, Batta G, Stevaert A, Vanderlinden E, Naesens L, Herczegh P, Borbás A.

Eur J Med Chem. 2018 Sep 5;157:1017-1030. doi: 10.1016/j.ejmech.2018.08.058. Epub 2018 Aug 22.

PMID:
30170320
18.

Promotion of a Reaction by Cooling: Stereoselective 1,2-cis-α-Thioglycoconjugation by Thiol-Ene Coupling at -80 °C.

Eszenyi D, Kelemen V, Balogh F, Bege M, Csávás M, Herczegh P, Borbás A.

Chemistry. 2018 Mar 26;24(18):4532-4536. doi: 10.1002/chem.201800668. Epub 2018 Mar 8.

PMID:
29457864
19.

A Sulfonozanamivir Analogue Has Potent Anti-influenza Virus Activity.

Hadházi Á, Li L, Bailly B, Maggioni A, Martin G, Dirr L, Dyason JC, Thomson RJ, Gao GF, Borbás A, Ve T, Pascolutti M, von Itzstein M.

ChemMedChem. 2018 Apr 23;13(8):785-789. doi: 10.1002/cmdc.201800092. Epub 2018 Mar 15.

PMID:
29453852
20.

Synthesis of α-l-Fucopyranoside-Presenting Glycoclusters and Investigation of Their Interaction with Photorhabdus asymbiotica Lectin (PHL).

Jančaříková G, Herczeg M, Fujdiarová E, Houser J, Kövér KE, Borbás A, Wimmerová M, Csávás M.

Chemistry. 2018 Mar 15;24(16):4055-4068. doi: 10.1002/chem.201705853. Epub 2018 Feb 19.

PMID:
29341313

Supplemental Content

Loading ...
Support Center